Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Head and Neck Neoplasms 193 Squamous Cell Carcinoma of Head and Neck 171 Oropharyngeal Neoplasms 35 Carcinoma, Squamous Cell 26 Nasopharyngeal Carcinoma 24 Laryngeal Neoplasms 21 Mouth Neoplasms 20 Radiation Injuries 15 Nasopharyngeal Neoplasms 12 Hypopharyngeal Neoplasms 12 Salivary Gland Neoplasms 11 Xerostomia 8 Neoplasms 8 Mucositis 7 Laryngeal Diseases 7 Tongue Neoplasms 6 Esthesioneuroblastoma, Olfactory 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma 6 Thyroid Neoplasms 5 Lung Neoplasms 5 Recurrence 4 Prostatic Neoplasms 4 Melanoma 4 Breast Neoplasms 4 Thyroid Carcinoma, Anaplastic 3 Rectal Neoplasms 3 Pharyngeal Neoplasms 3 Paranasal Sinus Neoplasms 3 Pancreatic Neoplasms 3

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 2 pimonidazole 1 fluoromisonidazole 1 alovudine 1 TH 302 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Nimorazole 1 Ipilimumab 1 Drug Therapy 1 AQ4N 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Radiotherapy × Head & Neck × Clear all

NCT01212354 2016-02-09

Escalox

Technical University of Munich

Phase 3 Unknown

Hypoxia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡